These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported Terminated 2006-001846-15 A placebo-controlled, randomised, double-blind, single dose proof of concept study of Kappaproct, in steroid resistant or steroid dependent patients with ulcerative colitis of mild to moderate degree 2009-04-15 due-trials
Not reported Terminated 2009-010756-10 Effect of an additional single dose of Kappaproct to corticosteroid treated patients with brain edema caused by brain tumor 2011-05-27 due-trials
Not reported 2011-003130-14 A placebo-controlled, double-blind, randomised study to assess the efficacy and safety of Kappaproct as an add-on to current practice in chronic active treatment refractory ulcerative colitis patients 2014-04-30 due-trials
Reported results 2016-004217-26 A Randomised Dose-Optimisation Study to Evaluate the Efficacy and Safety of Cobitolimod in Moderate to Severe Active Ulcerative Colitis Patients 2019-08-30 due-trials
Listed as ongoing, but also has a completion date and reported results 2021-002549-13 A Randomised Double-Blind Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of Cobitolimod as an Induction and Maintenance Therapy in Participants with Moderate to Sev... 2023-12-18 bad-data
Exempt, with results 2021-003023-14 Pharmacokinetics of Cobitolimod Enemas in Participants with active Ulcerative Colitis 2023-01-19 not-yet-due